Dataset Open Access

Smoking is associated with worse outcomes of COVID-19 particularly among younger adults: a systematic review and meta-analysis

Glantz, Stanton; Patanavanich, Roengrudee


Dublin Core Export

<?xml version='1.0' encoding='utf-8'?>
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Glantz, Stanton</dc:creator>
  <dc:creator>Patanavanich, Roengrudee</dc:creator>
  <dc:date>2020-09-30</dc:date>
  <dc:description>Introduction: Smoking impairs lung immune functions and damages upper airways, increasing risks of contracting and severity of infectious diseases.

Methods: We searched PubMed for studies published from January 1-May 25, 2020. We included studies reporting smoking behavior of COVID-19 patients and progression of disease, including death. We used a random effects meta-analysis and used meta-regression and lowess regressions to examine relationships in the data.

Results: We identified 47 peer-reviewed papers with a total of 31,871 COVID-19 patients, 5,759 (18.1%) experienced disease progression and 5,734 (18.0%) with a history of smoking. Among smokers, 29.2% experienced disease progression, compared with 21.1% of non-smokers. The meta-analysis confirmed an association between smoking and COVID-19 progression (OR 1.56, 95% CI 1.32-1.83, p=0.001). Smoking was associated with increased risk of death from COVID-19 (OR 1.19, 95% CI 1.05-1.34, p=0.007). We found no significant difference (p=0.432) between the effects of smoking on COVID-19 disease progression between adjusted and unadjusted analyses, suggesting that smoking is an independent risk factor for COVID-19 disease progression. We also found the risk of having COVID-19 progression among younger adults (p=0.023), with the effect most pronounced among people under about 45 years old.

Conclusions: Smoking is an independent risk for having severe progression of COVID-19, including mortality. The effects seem to be higher among young people.

Implications: Smoking prevention and cessation should remain a priority for the public, physicians, and public health professionals during the COVID-19 pandemic.</dc:description>
  <dc:description>Funding provided by: National Institute on Drug AbuseCrossref Funder Registry ID: http://dx.doi.org/10.13039/100000026Award Number: R01DA043950Funding provided by: National Institutes of HealthCrossref Funder Registry ID: http://dx.doi.org/10.13039/100000002Award Number: U54HL147127</dc:description>
  <dc:description>We conducted a systematic search using PubMed on May 25, 2020, with the search term: "((smoking) OR (characteristics) OR (risk factors) OR (retrospective*) OR (outcomes) OR (smoker*)) AND ((COVID-19) OR (COVID) OR (coronavirus) OR (sars cov-2) OR (sars cov 2))" for studies published between January 1, 2020 and May 25, 2020. A total of 2,600 studies were retrieved through the search.</dc:description>
  <dc:identifier>https://zenodo.org/record/4086492</dc:identifier>
  <dc:identifier>10.7272/Q6CF9NBQ</dc:identifier>
  <dc:identifier>oai:zenodo.org:4086492</dc:identifier>
  <dc:relation>url:https://zenodo.org/communities/covid-19</dc:relation>
  <dc:relation>url:https://zenodo.org/communities/dryad</dc:relation>
  <dc:relation>url:https://zenodo.org/communities/zenodo</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>https://creativecommons.org/publicdomain/zero/1.0/legalcode</dc:rights>
  <dc:title>Smoking is associated with worse outcomes of COVID-19 particularly among younger adults: a systematic review and meta-analysis</dc:title>
  <dc:type>info:eu-repo/semantics/other</dc:type>
  <dc:type>dataset</dc:type>
</oai_dc:dc>
60
23
views
downloads
Views 60
Downloads 23
Data volume 454.2 kB
Unique views 48
Unique downloads 20

Share

Cite as